Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial superoxide generation refers to the production of superoxide, a reactive oxygen species (ROS), within mitochondria. This process occurs primarily during oxidative phosphorylation at complexes I and III of the electron transport chain. Superoxide is then converted into hydrogen peroxide by superoxide dismutases. Mitochondrial ROS play roles in signaling, metabolic adaptation, and inflammation but can also contribute to cellular damage and disease when produced in excess. Targeting mitochondrial ROS has therapeutic potential for various diseases, including aging-related disorders and infections like COVID-19.
Scavenging superoxide to reduce oxidative stress\nModulating signaling pathways involved in inflammation and apoptosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Superoxide Generation (mtROS or mROS (for mitochondrial ROS, which includes superoxide)).